Picton Mahoney Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Sell |
23
-213,087
| -100% | -$9.26M | ﹤0.01% | 730 |
|
|
2025
Q1 | $13M | Sell |
213,110
-18,309
| -8% | -$1.12M | 0.22% | 82 |
|
|
2024
Q4 | $13.1M | Buy |
231,419
+98,139
| +74% | +$5.55M | 0.27% | 70 |
|
|
2024
Q3 | $6.9M | Buy |
+133,280
| New | +$6.9M | 0.23% | 131 |
|
|
2021
Q1 | – | Sell |
-251,610
| Closed | -$15.6M | – | 336 |
|
|
2020
Q4 | $15.6M | Sell |
251,610
-24,888
| -9% | -$1.54M | 0.74% | 31 |
|
|
2020
Q3 | $16.7M | Sell |
276,498
-90,051
| -25% | -$5.43M | 0.92% | 21 |
|
|
2020
Q2 | $21.6M | Buy |
366,549
+829
| +0.2% | +$48.7K | 1.24% | 12 |
|
|
2020
Q1 | $20.4M | Buy |
+365,720
| New | +$20.4M | 1.15% | 10 |
|
|
2016
Q4 | – | Sell |
-115,800
| Closed | -$6.25M | – | 192 |
|
|
2016
Q3 | $6.25M | Sell |
115,800
-306,980
| -73% | -$16.6M | 0.42% | 79 |
|
|
2016
Q2 | $31.1M | Buy |
422,780
+53,300
| +14% | +$3.92M | 1.92% | 3 |
|
|
2016
Q1 | $23.6M | Sell |
369,480
-63,890
| -15% | -$4.08M | 1.51% | 16 |
|
|
2015
Q4 | $29.8M | Buy |
433,370
+70,400
| +19% | +$4.84M | 1.78% | 9 |
|
|
2015
Q3 | $21.5M | Sell |
362,970
-30,530
| -8% | -$1.81M | 1.25% | 24 |
|
|
2015
Q2 | $26.2M | Sell |
393,500
-43,700
| -10% | -$2.91M | 1.29% | 11 |
|
|
2015
Q1 | $28.2M | Buy |
437,200
+156,400
| +56% | +$10.1M | 1.08% | 12 |
|
|
2014
Q4 | $16.6M | Buy |
280,800
+3,400
| +1% | +$201K | 0.79% | 43 |
|
|
2014
Q3 | $14.2K | Sell |
277,400
-6,000
| -2% | -$307 | 0.77% | 48 |
|
|
2014
Q2 | $13.7K | Buy |
283,400
+37,200
| +15% | +$1.8K | 0.81% | 43 |
|
|
2014
Q1 | $12.8M | Buy |
+246,200
| New | +$12.8M | 0.74% | 45 |
|